David A Stock Selected Research

rimegepant sulfate

1/2022	P-Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects.
1/2022	Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women.
1/2021	Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.
11/2020	Pain Freedom at 2-8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant: A Response.
1/2020	Testing rimegepant for migraine-time to revise the trial design? - Authors' reply.
11/2019	Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
1/2019	Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Stock Research Topics

Disease

6	Migraine Disorders (Migraine) 01/2022 - 01/2019
4	Pain (Aches) 11/2020 - 02/2006
1	Body Weight (Weight, Body) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Nausea 01/2019
1	Chemical and Drug Induced Liver Injury 01/2016
1	Drug Eruptions (Drug Eruption) 01/2016
1	Lipodystrophy 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Digestive System Diseases 10/2015
1	Urolithiasis 04/2009
1	Neoplasms (Cancer) 04/2009
1	Dementia (Dementias) 10/2006
1	Diabetic Neuropathies (Diabetic Neuropathy) 02/2006
1	Hyperalgesia 02/2006

Drug/Important Bio-Agent (IBA)

7	rimegepant sulfateIBA 01/2022 - 01/2019
5	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022 - 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Quinidine (Chinidin)FDA LinkGeneric 01/2022
1	lasmiditanIBA 11/2020
1	ubrogepantIBA 11/2020
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2019
1	TabletsIBA 01/2019
1	Tenofovir (Viread)FDA Link 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Atazanavir Sulfate (Reyataz)FDA Link 10/2015
1	fostemsavirIBA 10/2015
1	Ritonavir (Norvir)FDA Link 10/2015
1	IonsIBA 04/2009
1	Staphylococcal Protein A (Protein A)IBA 04/2009
1	Citric Acid (Citrate)FDA LinkGeneric 04/2009
1	PPAR gammaIBA 04/2009
1	Scopolamine (Hyoscine)FDA Link 10/2006
1	Amyloid beta-PeptidesIBA 10/2006
1	Amitriptyline (Elavil)FDA LinkGeneric 02/2006
1	Streptozocin (Streptozotocin)FDA Link 02/2006
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2006
1	Therapeutic UsesIBA 02/2006